Comparison Effects Of Different Exercise Approaches On Type 2 DM Women

Not Applicable

• Conditions: Type 2 Diabetes
• Interventions: Behavioral: Supervised Group Exercise Program; Behavioral: Video Based Home Exercise Program; Behavioral: Blue Prescription Exercise Program

• Registration Number: NCT05479435
• Lead Sponsor: Istanbul Medipol University Hospital

Brief Summary

Type 2 Diabetes Mellitus (T2DM) is one of the most common metabolic diseases with a complex, multifactorial aetiology, and is a chronic disease with various clinical and biochemical manifestations. It has been known for a long time that T2DM treatments are medication, diet, and exercise. Exercise can improve blood glucose control, increase insulin sensitivity, respiratory capacity, well-being and cognitive functions, regulate lipid profile, blood pressure, reduce cardiovascular disease risk, abdominal obesity, weight. Although there are many studies in the literature on the effects of exercise in T2DM, there is no consensus on which exercise protocol is more effective. In the studies, the obstacles in front of the diabetic patients' adaptation to exercise; laziness, lack of motivation and energy, embarrassment from family and social environment, lack of support, timelessness, financial problems, lack of space to exercise, fear of hypoglycaemia, pain, stiffness, fatigue, shortness of breath, presence of additional diseases, fear of injury. Blue Prescription (BP) is a model developed to facilitate the continuous participation in physical activity. In traditional home programs, patients are told what to do. The BP approach, on the other hand, involves providing the person with options for physical activity, removing the barriers to activity instead of the classical home exercise program or physical activity counselling, and being in communication with the way the person wants during this process. This approach has been developed to facilitate participation in physical activity and to ensure the sustainability of physical activity in individuals with chronic diseases. Philosophy of the approach aims to increase the activity level gradually, improve the quality of life and continuous participation in the activity with motivational interview, continuous support, communication and activity diary, instead of recommending physical activity with classical methods due to the different needs, desires and tastes of people. Studies using the BP in the literature have focused on Multiple Sclerosis and stroke, and no publications on other chronic diseases have been found. The aim of this study is to examine the effects of BP, video-based home exercise and supervised group exercises on HbA1c, physical activity level, functional capacity and other metabolic control variables in primary care women with T2DM.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-09-01
• Study First Submitted: 2022-01-26
• Status Verified: 2022-07
• Study First Submitted QC: 2022-07-27
• Last Update Submitted: 2022-07-27
• Study First Posted: 2022-07-29
• Last Update Posted: 2022-07-29
• Primary Completion: 2022-10-01
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

1. Between 25-65 years of age
2. Having Type 2 DM for at least 5 years
3. HbA1c value> 6.5% / Fasting blood glucose> 126 mg / dl
4. Ability to walk independently
5. Volunteering to participate in research

Exclusion Criteria

1. Type 1 DM
2. Using insulin
3. Orthopedic and neurological diseases that prevent exercise
4. Having cardiovascular, pulmonary and systemic diseases in which exercise is contraindicated.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Supervised Exercise Group	Supervised Group Exercise Program	Participants will perform an exercise program 3 days a week with a physiotherapist. The group will be held maximum 10 people.
Video Based Home Exercise Group	Video Based Home Exercise Program	Participants will get videos by different ways (closed link youtube, whatsapp, flash driver etc.). They will perform exercises 3 days a week. İnvestigator will phone them to ask whether they do the program or not. They will write an activity diary.
Blue Prescription Group	Blue Prescription Exercise Program	Participants will get an exercise program, which is designed by their needs, desires and abilities. They will perform a desired exercise program 3 days a week and they will make an interview for motivation and/or modifying the program one day a week. They will write an activity diary.

Primary Outcome Measures

Name	Time	Method
Low Density Lipoprotein	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It provides the transport of cholesterol synthesized in the liver to the tissues and blood vessels. The unit of measurement is mg/dL, the reference range is 0- 130 mg/dL.
Functional capacity Change With 6-minute Walking Test	Change from Baseline 6-minute Walking Test Results at 12 weeks.	It will be performed in a 30 meter long corridor or in an open area. The participant will be asked to walk without running at the highest speed for 6 minutes. Before and during the march, the participant will be verbally encouraged and motivated. Blood pressure and heart rate values and how many meters they walked will be recorded as a result of the test.
High Density Lipoprotein	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It takes part in the transport of cholesterol from tissues and vessels to the liver and in the synthesis of vitamin D. The unit of measurement is mg/dL, the reference range is 30-96 mg/dL.
Physical Activity Level Change	Change from Baseline Physical Activity Level at 12 weeks.	It will be assessed by the International Physical Activity Questionnaire- short form (IPAQ). The questionnaire provides information about the time spent by the individual in light, moderate and vigorous activities and sitting in the last 7 days. The MET-min / week score is obtained by multiplying the MET value (metabolic equivalent) by days and minutes for each activity level. Physical activity levels are classified as physically inactive (\<600 MET-min / week), low physical activity (600-3000 MET-min / week) and adequate physical activity (\> 3000 MET-min / week).
C-reactive Protein	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It is a protein produced in the liver. It is a protein that is produced by cells and secreted into the blood when the body reacts to conditions such as infection, tumor, trauma, and undertakes various biochemical tasks. The unit of measurement is mg/dL, the reference range is 0-0.5 mg/dL.
Glycosylated Hemoglobin Change	Change from Baseline Glycosylated Hemoglobin at 12 weeks.	Hemoglobin A1c is a blood test used to measure the effectiveness of treatment in diabetes, and sometimes to diagnose diabetes.
Diastolic Blood Pressure	In the beginning of the intervention and at the end of the exercise program (12 weeks).	The pressure that builds up in the blood vessels as the heart relaxes. It is measured with a sphygmomanometer. It is placed 2.5 to 3 cm above the inside of the elbow. The stethoscope is clamped under the cuff and pressed lightly. The sphygmomanometer air is then inflated to 20 to 30 mmHg above the level at which blood pressure disappears. The control valve should be opened slightly and air should be vented to 2-4 mmHg per second. The value at which the sound is inaudible is considered the diastolic blood pressure. The reference range averages 70 - 90 mmHg.
Functional Capacity Change with Timed Up And Go Test	Change from Baseline Timed Up And Go Test Results at 12 weeks.	The participant will sit on a chair without armrests, stand up with the command to start, walk 3 meters towards the designated point, turn around and walk to the starting point again and sit. The test is repeated 3 times and the average is taken. The time will be recorded in seconds.
Fasting Plasma Glucose	In the beginning of the intervention and at the end of the exercise program (12 weeks).	Measured level of glucose in the blood after 8 to 12 hours of fasting. The unit of measurement is mg/dL, the reference range is 70-110 mg/dL.
Total Cholesterol	In the beginning of the intervention and at the end of the exercise program (12 weeks).	Total cholesterol is a value that shows the total amount of cholesterol in the blood. In addition to LDL and HDL, triglyceride levels are also used to calculate total cholesterol. The unit of measurement is mg/dL, the reference range is 70-200 mg/dL.
Triglyceride	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It is a storage nutrient molecule formed by the combination of fatty acids and glycerol molecules, which form the structure of fats in foods. The unit of measurement is mg/dL, the reference range is 0-250 mg/dL.
Systolic Blood Pressure	In the beginning of the intervention and at the end of the exercise program (12 weeks).	The pressure that builds up in the blood vessels when the heart contracts. It is measured with a sphygmomanometer. It is placed 2.5 to 3 cm above the inside of the elbow. The stethoscope is clamped under the cuff and pressed lightly. The sphygmomanometer air is then inflated to 20 to 30 mmHg above the level at which blood pressure disappears. The control valve should be opened slightly and air should be vented to 2-4 mmHg per second. The first sound heard as the air is evacuated determines the systolic blood pressure. The reference range averages 120 - 130 mmHg.
Hearth Rate	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It is the value that shows how many times the heart beats in a minute. Measurement from the wrist: measured from the radial artery with 3 fingers with the palm facing up. The reference range is between 60 and 100 beats per minute (bpm).

Secondary Outcome Measures

Name	Time	Method
Weight	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It will be measured with a standard weighing instrument.
Body Mass Index (BMI)	In the beginning of the intervention and at the end of the exercise program (12 weeks).	BMI will be calculated by dividing body weight (kg) by height square (m ²).
Body Fat Ratio Change with Bioelectrical Impedance Analysis (BIA)	Change from Baseline Bioelectrical Impedance Analysis at 12 weeks.	-Bioelectrical Impedance Analysis (BIA): The basic principle is to measure the impedance by using the resistance and conductivity that a very small amount of electrical current encounters when passing through tissues. Tanita SC-330 will be used in our study.
Body Fat Ratio Change with Skinfold Analysis	Change from Baseline Skinfold Analysis at 12 weeks.	All measurements will be made on the right side of the body. The caliper will be placed approximately 1 cm from the thumb and index finger, and 1-2 seconds will be waited before the caliper is read. Body fat percentages of individuals will be calculated using Jackson-Pollock 7 region equations; Triceps, Subscapularis, Midaxillary, Abdominal, Chest, Suprailiac.
Flexibility Change With Trunk Lateral Flexion Measure	Change from Baseline Trunk Lateral Flexion Measure at 12 weeks.	The participant will be asked to stand with their feet slightly open, parallel to each other, arms next to the trunk. Mark the distal end of the third finger of the hand on the thigh, and the participant will be asked to perform lateral flexion. The point where the distal of the third finger comes from is marked again. The distance between the two points is cm. will be recorded in terms.
Depression	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It will be evaluated with the Beck Depression Scale. The scale is used to measure the level of depression with a 21-item multiple-choice question.
Height	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It will be measured with a stadiometer. Head, shoulders, back, hips, calves and heels will touch the stadiometer, stand upright with feet shoulder-width apart, slide of height meter will be pulled down.
Flexibility Change With Fingertip-to-floor Distance Measure	Change from Baseline Fingertip-to-floor Distance Measure at 12 weeks.	During the test, the participant will be asked to lean forward without bending their knees and try to touch the fingertip. The distance between the tip of the third finger of the hand and the ground will be measured and the result will be recorded in cm.
Life Quality	In the beginning of the intervention and at the end of the exercise program (12 weeks).	Diabetes will be assessed by the Quality of Life Scale (DQOL). The questionnaire with 4 sub-sections consists of 45 questions. Satisfaction section, Very satisfied- Moderately pleased- None- Slightly satisfied- Not satisfied at all options; psychological effect of treatment, Never- Very Rare- Sometimes -Frequently -Always from the options; The anxiety / anxiety about the later state of the disease consists of Never - Rarely - Sometimes Often - Always and the social and occupational anxiety section, Never - Rarely - Sometimes - Often - Always. With these sections, the questionnaire evaluates the quality of life from different angles. High score is associated with higher quality of life.
Contentment	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It will be evaluated with The Diabetes Treatment Satisfaction Questionnaire (DTSQ). The questionnaire measures how the individual perceives glycemic control and satisfaction with the treatment. Suitable for Type 1 DM and Type 2 DM. It consists of 8 items and is scored on a 0-6 Likert scale. 6 items 1, 4, 5, 6, 7, 8); It meets to determine satisfaction between 0 (not at all) and 6 (very satisfied). Of the remaining items, 2, 0 (never) to 6 almost always) measure the frequency of detection of hyperglycemia, and item 3 measures the frequency of detecting hypoglycemia. The highest score is calculated as 36.
Neck Circumference	In the beginning of the intervention and at the end of the exercise program (12 weeks).	In the anatomical position, the tape measure is measured just below the thyroid cartilage.
Waist Circumference	In the beginning of the intervention and at the end of the exercise program (12 weeks).	It is measured at the thinnest point between the lowest rib and anterior superior to the processus spina ilica in the anatomical position.
Hip Circumference	In the beginning of the intervention and at the end of the exercise program (12 weeks).	Measured at the widest point of the Gluteus Maximus muscle in the anatomical position

Trial Locations

Locations (1)

Istanbul Medipol University; 🇹🇷 Istanbul, Turkey